For the Inventor, By the Inventor

Enter assignee name

Luxembourg, Luxembourg

Mitotech Sa

USPTO Granted Patents = 17

% Expired Patents = 29.4

CIPO Patents = 2

EPO Patents = 4

Trademarks = 1

Forward Citations = 15

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Maxim Vladimirovich Skulachev (16 out of 21 patents)

Vladimir Petrovich Skulachev (15 out of 15 patents)

Maxim Viktorovich Egorov (4 out of 4 patents)

4. Roman A Zinovkin (3 out of 3 patents)

5. Vadim N Tashlitsky (3 out of 3 patents)

6. Dmitry Borisovich Zorov (2 out of 2 patents)

7. Lawrence Friedhoff (2 out of 9 patents)

8. Olga Y Pletushkina (2 out of 2 patents)

9. Alexander A Andreev-Andrievsky (2 out of 2 patents)

10. Tatiana V Zinevich (2 out of 2 patents)

11. Nikolai Konstantinovich Isaev (1 out of 1 patent)

12. Fedor Fedorovich Severin (1 out of 1 patent)

13. Elena Viktorovna Stelmashuk (1 out of 1 patent)

14. Nadezhda Anatolievna Kapay (1 out of 1 patent)

15. Egor Y Plotnikov (1 out of 1 patent)

17 patents: Sort by Forward Citations

1. 10213392 - Pharmaceutical composition for use in medical and veterinary ophthalmology (2019-02-26),

2. 10188669 - Mitochondria-targeted antioxidants for treatment of age-related brain disorders (2019-01-29),

3. 9744180 - Pharmaceutical formulations containing mitochondrially targeted antioxidants (2017-08-29),

4. 9724313 - Pharmaceutical composition for use in medical and veterinary ophthalmology (2017-08-08),

5. 9572890 - Oral formulations of mitochondrially-targeted antioxidants and their preparation and use (2017-02-21),

6. 9572821 - Pharmaceutical compositions for preventing and treating eye pathologies (2017-02-21),

7. 9439916 - Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition (2016-09-13),

8. 9427444 - Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages (2016-08-30),

9. 9408859 - Pharmaceutical compositions useful for preventing and treating cancer (2016-08-09),

10. 9328130 - Method of treating organism by biologically active compounds specifically delivered into mitochondria, pharmaceutical composition required for the use of the method and a compound applicable for this purpose (2016-05-03),

11. 9308214 - Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations (2016-04-12),

12. 9233903 - Pharmaceutical substances on the basis of mitochondria-addressed antioxidants (2016-01-12),

13. 9192676 - Oral formulations of mitochondrially-targeted antioxidants and their preparation and use (2015-11-24),

14. 8658624 - Pharmaceutical compositions for preventing and treating eye pathologies (2014-02-25),

15. 8557733 - Composition for regenerating and stimulating growth of plants and for adapting plants to different stress factors (2013-10-15),

Company Overview

Mitotech Sa is a biotechnology company based in Luxembourg, specializing in the development of innovative therapies aimed at addressing mitochondrial dysfunction. The organization focuses on harnessing advanced scientific research to create solutions for various age-related diseases and conditions. Mitotech's expertise lies in the intersection of molecular biology and pharmacology, positioning it as a key player in the field of regenerative medicine and therapeutic advancements in Europe.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#50 in Luxembourg

#64 in Luxembourg

#35,918 in the World

Luxembourg, Luxembourg

Mitotech Sa

Forward Citations = 15

29 inventors:

Maxim Vladimirovich Skulachev (16 out of 21 patents)

Vladimir Petrovich Skulachev (15 out of 15 patents)

Maxim Viktorovich Egorov (4 out of 4 patents)

4. Roman A Zinovkin (3 out of 3 patents)

5. Vadim N Tashlitsky (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mitotech Sa. Retrieved from https://idiyas.com/company/mitotech-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…